tiprankstipranks
Trending News
More News >
Medtide, Inc. Class H (HK:3880)
:3880
Hong Kong Market

Compare Medtide, Inc. Class H (3880) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Medtide, Inc. Class H
HK$30.00
HK$3.97B
32.53
-11.43%
Genor Biopharma Holdings Limited
HK$3.06
HK$5.08B
55.63
31.38%
Jacobio Pharmaceuticals Group Co., Ltd.
HK$7.63
HK$4.92B
-95.43
326.76%
Viva Biotech Holdings
HK$1.76
HK$5.58B
30.93
237.50%
Clover Biopharmaceuticals Ltd.
HK$2.37
HK$3.05B
-2.83
941.28%
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$6.15
HK$3.94B
-5.62
-9.50%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:3880
Medtide, Inc. Class H
27.28
-4.92
-15.28%
HK:6998
Genor Biopharma Holdings Limited
2.47
0.59
31.38%
HK:1167
Jacobio Pharmaceuticals Group Co., Ltd.
6.06
4.67
335.97%
HK:1873
Viva Biotech Holdings
2.70
1.90
237.50%
HK:2197
Clover Biopharmaceuticals Ltd.
2.27
2.05
931.82%
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
4.67
-0.35
-6.97%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts